Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002083069A3 Recombinant proteins of orientia tsutsugamushi
08/07/2003WO2002079403A3 Method for modifying plant biomass
08/07/2003WO2002077275A3 Diagnostic method for determining abnormality of cloned embryos
08/07/2003WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses
08/07/2003WO2002072784A3 Heat stable mutants of starch biosynthesis enzymes
08/07/2003WO2002068631A3 Plasmid for insertional mutagenesis in bacteria
08/07/2003WO2002066642A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003WO2002064157A3 Localized myocardial injection method for treating ischemic myocardium
08/07/2003WO2002059360A3 Ammonium sulfate for neutralization of inhibitory effects
08/07/2003WO2002059359A3 Method for non-redundant library construction
08/07/2003WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof
08/07/2003WO2002053588A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci
08/07/2003WO2002052023A3 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
08/07/2003WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes
08/07/2003WO2002050274A3 Seleno-cysteine containing protein zsel1
08/07/2003WO2002048340A3 Transgenci mice containing cashgene disruptions
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002045659A9 Novel therapeutics for heart failure and aging
08/07/2003WO2002038748A3 Mammalian sex selection using genetic modification
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002022822A3 Plant derived bag homologues
08/07/2003WO2002020850A3 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
08/07/2003WO2002020848A3 Gene and sequence variation associated with cancer
08/07/2003WO2002020751A3 Hyperglycosylated polypeptides
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002016625A3 Plant polynucleotides encoding prenyl proteases
08/07/2003WO2002012331A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
08/07/2003WO2002010374A3 Gene silencing using mrna-cdna hybrids
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003WO2002004681A3 Method of detection by enhancement of silver staining
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
08/07/2003WO2001090417A3 Materials and methods for detection of nucleic acids
08/07/2003WO2001090149A3 G protein-coupled receptors
08/07/2003WO2001066773A3 Nucleic acids that code for oxidosqualene cyclases
08/07/2003WO2001057252A3 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
08/07/2003US20030150028 Comprises nucleotide sequences coding hydrolase for use in transforming and generating freeze/heat/drought resistance in monocotyledons/dicotyledons
08/07/2003US20030150027 Increasing seed and biomass production via expressing shrunken (SH2REV6) gene in genetically engineered monocotyledon/dicotyledons
08/07/2003US20030150026 Genes involved in brassinosteroid hormone action in plants
08/07/2003US20030150025 DAS5, a P450 protein involved in the brassinosteroid biosynthesis pathway in plants
08/07/2003US20030150024 Plant MSH2 sequences and methods of use
08/07/2003US20030150023 Starch
08/07/2003US20030150022 Compositions and methods for regulating metabolism in plants
08/07/2003US20030150021 Maize 4-alpha-glucanotransferase
08/07/2003US20030150020 Plant fatty acid desaturases and alleles therefor
08/07/2003US20030150019 Comprises plant viral RNA sequences comprising cis-acting replication elements for transfection and expression of heterologous proteins in plants such as tobacco
08/07/2003US20030150018 Comprises nucleotide sequences coding insecticidal proteins (cry proteins) for insect resistance; biological pest control
08/07/2003US20030150017 Preparing pineapple plant resistance to nematode infection and/or infestation; disease resistant plants; nematocides
08/07/2003US20030150015 Aromatic methyltransferases and uses thereof
08/07/2003US20030150014 Maize cellulose synthases and uses thereof
08/07/2003US20030150013 Inducing plant somatic embryogenesis in absence of hormones using expression vector coding glucocorticoid and/or estrogen receptors and the regulatory proteins leafy cotyledon 1 (LEC1) and somatic embryogenesis receptor-like kinase (SERK)
08/07/2003US20030150012 Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
08/07/2003US20030150011 Transgenic plants with altered levels of phenolic compounds
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030150009 Using senescence asociated gene promoter (SAG12), isopentyl transferase and biosynthesis of cytokinins to inhibiting apoptosis in plants
08/07/2003US20030150008 Transgenic plants containing altered levels of steroid compounds
08/07/2003US20030150007 Method of generating transgenic organisms using transposons
08/07/2003US20030150006 Gene transfer in poultry by introduction of embryo cells in ovo
08/07/2003US20030150004 Transgenic mice expressing human CAR receptor (retinoic acid receptors), wherein activity is increased via administration of 1,4-bis(2-(3,5-dichloropyridyloxy))benzene; cytochromes
08/07/2003US20030150003 Novel apolipoprotein gene involved in lipid metabolism
08/07/2003US20030150002 Generating transgenic, disease resistant cattle using cryopresevred regenerated mammalian oocytes
08/07/2003US20030150001 Generating animal models using N-ethyl-N- nitrosourea (ENU)
08/07/2003US20030150000 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom
08/07/2003US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149534 Gene associated with cancer
08/07/2003US20030149258 Multiplex PCR primer set for human HNF-1alpha gene amplification
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149254 Retroviral vector comprising green fluorescent reporter protein for use as diagnostic tool in genetic engineering
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149244 Adjusting affinity of Fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents
08/07/2003US20030149238 Novel compounds
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149236 Nucleotide sequences coding interleukin (IL)-11 receptor for development of agonists, antagonists, therapeutic and diagnostic reagents; antiproliferative/inflammatory agents
08/07/2003US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs
08/07/2003US20030148989 For therapy of non small cell lung cance, non-Hodgkin's lymphoma in humans
08/07/2003US20030148988 Telomere-encoding synthetic DNA nanocircles, and their use for the elongation of telomere repeats
08/07/2003US20030148987 Selective 11beta-HSD inhibitors and methods of use thereof
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
08/07/2003US20030148984 Molecular chemotherapy enhancement of radiotherapy
08/07/2003US20030148983 Polynucleotide therapy
08/07/2003US20030148980 Hybrid oligonucleotide phosphorothioates
08/07/2003US20030148979 Traversal of nucleic acid molecules through a fluid space and expression in repair cells
08/07/2003US20030148976 For therapy of cancer, infectious disease, and allergic disorders
08/07/2003US20030148975 Method of achieving persistent transgene expression
08/07/2003US20030148974 Antisense modulation of akt-3 expression
08/07/2003US20030148972 Hereditary hemochromatosis gene
08/07/2003US20030148971 Treatment of inflammatory and malignant diseases
08/07/2003US20030148969 Antisense modulation of mucin 1, transmembrane expression
08/07/2003US20030148968 Delivering a transgene encoding an angiogenic protein or peptide to myocardium of patient by introducing a vector comprising transgene into coronary artery, wherein the transgene is is delivered to the myocardium and expressed
08/07/2003US20030148965 Pesticide comprising a macrolide compound in free form or in agrochemically useful salt form as active ingredient and at least one auxiliary is applied to the pests or their environment
08/07/2003US20030148958 For therapy and prophylaxis of muscular dystrophy
08/07/2003US20030148957 Corticotropin releasing factor 2 receptor agonists
08/07/2003US20030148956 For therapy and prophylaxis of muscular dystrophy
08/07/2003US20030148951 Human EMR2, a G-protein coupled receptor from the EGF_TM7 family
08/07/2003US20030148949 Administering a trefoil peptide or biologically active fragment thereof to a skin lesion or region of the skin where a lesion is to be prevented; wound healing agents which can speed healing, reduce pain and delay/prevent lesions
08/07/2003US20030148948 Super-active porcine growth hormone releasing hormone analog
1 ... 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 ... 4023